How to buy Enfusion stock

Enfusion, which produces Cloud-based investment management software, wrapped its IPO, selling 15.322 million shares at $17 per share, the high end of its announced price range.

Shares of Enfusion will begin trading on the NYSE later today under the ticker symbol ENFN, but shares are available for limit orders on Robinhood and other platforms.

Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Enfusion stock price (NYSE: ENFN)

Use our graph to track the performance of ENFN stocks over time.

Enfusion shares at a glance

• Key figures

Information last updated 2022-06-29.

Latest market close	$10.47
52-week range	$7.80 - $23.21
50-day moving average more info button	$10.95
200-day moving average more info button	$15.24
Wall St. target price	$13.50
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-3.05

Buy Enfusion shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Enfusion stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Enfusion price performance over time

Historical closes compared with the close of $10.47 from 2022-07-01

1 week (2022-06-24)	-6.68%
1 month (2022-06-03)	-5.25%
3 months (2022-04-04)	-18.20%
6 months (2022-01-04)	-47.17%

1 year (2021-06-30)	N/A
2 years (2020-06-30)	N/A
3 years (2019-06-30)	N/A
5 years (2017-06-30)	N/A

Enfusion financials

Revenue TTM	$121.5 million
Gross profit TTM	$79.9 million
Return on assets TTM	-241.58%
Return on equity TTM	-2085.37%
Profit margin	-139.68%
Book value	$0.84
Market capitalisation more info button	$691.9 million

TTM: trailing 12 months

Enfusion share dividends

We're not expecting Enfusion to pay a dividend over the next 12 months.

You may also wish to consider:

• X Financial Class A (XYF.US) (10.53% forward annual dividend yield)

Enfusion overview

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois. .

Frequently asked questions

What percentage of Enfusion is owned by insiders or institutions?
Currently 2.156% of Enfusion shares are held by insiders and 112.985% by institutions. How many people work for Enfusion?
Latest data suggests 892 work at Enfusion. When does the fiscal year end for Enfusion?
Enfusion's fiscal year ends in December. Where is Enfusion based?
Enfusion's address is: 125 South Clark Street, Chicago, IL, United States, 60603 What is Enfusion's ISIN number?
Enfusion's international securities identification number is: US2928121043